A detailed history of Ubs Asset Management Americas Inc transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,220,322 shares of SOPH stock, worth $7.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,220,322
Previous 2,222,347 0.09%
Holding current value
$7.35 Million
Previous $10.2 Million 20.38%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $4.8 $6,459 - $9,720
-2,025 Reduced 0.09%
2,220,322 $8.1 Million
Q2 2024

Aug 13, 2024

BUY
$4.46 - $5.55 $9.91 Million - $12.3 Million
2,222,347 New
2,222,347 $10.2 Million

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $212M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.